We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,056 results
  1. Hereditary Lobular Breast Cancer: A Newly Defined Syndrome

    Germline CDH1 mutations were first identified in 1998 in families with a strong history of early-onset gastric cancer. Now, 25 years on, it appears...
    Vanessa Blair, Antonia Girardi, Giovanni Corso in Hereditary Gastric and Breast Cancer Syndrome
    Chapter 2023
  2. Hereditary Lobular Breast Cancer Syndrome: Role of Surgery

    Hereditary lobular breast cancer is a novel and rare inherited syndrome, and it represents a multifaceted and fascinating clinical entity. In recent...
    Francesca Magnoni, Antonia Girardi, Paolo Veronesi in Hereditary Gastric and Breast Cancer Syndrome
    Chapter 2023
  3. Reporting on invasive lobular breast cancer in clinical trials: a systematic review

    Invasive lobular breast cancer (ILC) differs from invasive breast cancer of no special type in many ways. Evidence on treatment efficacy for ILC is,...

    Karen Van Baelen, Josephine Van Cauwenberge, ... Christine Desmedt in npj Breast Cancer
    Article Open access 20 March 2024
  4. Identification of the Shared Gene Signatures and Biological Mechanisms in Hyperplastic Enlarged Lobular Units and Breast Cancer

    Breast cancer is a common cancer worldwide. Hyperplastic enlarged lobular units (HELUs) are common changes in the breasts of adult women. HELUs may...

    Kuiyuan Tong, Zihao Yang, ... Feng Jiang in Biochemical Genetics
    Article 08 December 2023
  5. Pathology and Somatic Alterations in Hereditary Lobular Breast Cancers

    The most frequent special histological type of breast cancer is represented by invasive lobular carcinoma (ILC), which makes up about 15% of all...
    Francesca Maria Porta, Marta Cruz Blanco, ... Elena Guerini-Rocco in Hereditary Gastric and Breast Cancer Syndrome
    Chapter 2023
  6. Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer

    Background

    Invasive Lobular Carcinoma (ILC) is a morphologically distinct breast cancer subtype that represents up to 15% of all breast cancers....

    John Alexander, Koen Schipper, ... Syed Haider in British Journal of Cancer
    Article Open access 10 April 2024
  7. Breast Cancer

    Breast cancers are a major cause of mortality in females, on a par with lung and colon cancers. One topic in this chapter are the causes of breast...
    Wolfgang A. Schulz in Molecular Biology of Human Cancers
    Chapter 2023
  8. Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease

    Background

    Intra-ductal cancer (IDC) is the most common type of breast cancer, with intra-lobular cancer (ILC) coming in second. Surgery is the...

    Hassan A. Saad, Azza Baz, ... Lotfy A. Ibrahim in BMC Immunology
    Article Open access 25 January 2024
  9. Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics

    Women with germline pathogenic variants in CDH1 , which encodes E-cadherin protein, are at increased lifetime risk of invasive lobular carcinoma...

    Lauren A. Gamble, Paul H. McClelland, ... Jeremy L. Davis in npj Breast Cancer
    Article Open access 27 September 2023
  10. Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer

    Purpose

    The aim of the study was to compare the difference in survival between invasive ductal (IDC) and lobular carcinoma (ILC).

    Methods ...
    Menekse Göker, Hannelore Denys, ... Geert Braems in Breast Cancer Research
    Article Open access 22 November 2023
  11. Immunotherapy in Breast Cancer

    Breast cancer affects 12% of women worldwide. Although advances in systemic, surgical, and radiation therapy approaches will cure a large proportion...
    Jenna Hoppenworth, Roberto A. Leon-Ferre in The Basics of Cancer Immunotherapy
    Chapter 2024
  12. Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer

    While adjuvant treatment with the selective-estrogen receptor modulator (SERM) tamoxifen has been the standard of care for pre-menopausal patients...

    Helena Record, Elle Clelland, ... Rita A. Mukhtar in npj Breast Cancer
    Article Open access 26 October 2023
  13. Lobular Carcinoma of the Breast: Spectrum of Imaging Findings and New Emerging Technologies on the Horizon

    Invasive lobular carcinoma (ILC) is the second most common histologic form of breast cancer, representing 5% to 15% of all invasive breast cancers....
    Anna Rotili, Luca Nicosia, ... Enrico Cassano in Hereditary Gastric and Breast Cancer Syndrome
    Chapter 2023
  14. Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis

    This is a secondary data analysis of the TIPPING study, which included 1,121 patients with stage I-III breast cancer who had enumeration of CTCs (by...

    Silver Alkhafaji, Denise M. Wolf, ... Rita A. Mukhtar in npj Breast Cancer
    Article Open access 26 February 2024
  15. Breast Cancer

    Breast cancer is currently the most diagnosed cancer in the female population, with a prevalence of 1 in 8 women.
    Emilia Marrazzo, Chiara Annunziata Pasqualina Anghelone, Elena Vittoria Longhi in Managing Psychosexual Consequences in Chronic Diseases
    Chapter 2023
  16. Biosimilars in Breast Cancer

    Breast cancer is a significant health concern globally, leading to maximum mortalities amongst women worldwide, which is 11.6% of all cancers...
    Chapter 2024
  17. Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials

    Background

    Invasive lobular breast carcinomas (ILC) have different histological features compared to non-special type carcinomas (NST), but the effect...

    Davut Dayan, Stefan Lukac, ... Thomas W. P. Friedl in Breast Cancer Research
    Article Open access 14 December 2023
  18. The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining

    Background

    Tamoxifen (TAM) resistance to invasive lobular cell carcinoma is a challenge for breast cancer treatment. This study explored the role of...

    Dong Xu, Yiqi Zhang, Feng ** in BMC Cancer
    Article Open access 09 December 2021
  19. Epigenetics of Breast Cancer

    Epigenetic modulations of gene expression, post-transcriptional silencing of messenger RNA (mRNA), and post-translational modifications of protein...
    Madhumita Roy, Jaydip Biswas, Amitava Datta in Genetics and Epigenetics of Breast Cancer
    Chapter 2023
  20. Hereditary Gastric and Breast Cancer Syndrome CDH1: One Genotype with Multiple Phenotypes

    In this book the editors and authors provide a comprehensive overview on basic research and clinical aspects of hereditary breast and gastric tumors....

    Giovanni Corso, Paolo Veronesi, Franco Roviello
    Book 2023
Did you find what you were looking for? Share feedback.